FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to occupational medicine and therapy. During the medical examination of the employee, a complex of individual signs is detected: presence of snoring, daytime sleepiness, sleepiness at work, total score by Epworth questionnaire, arterial hypertension, diabetes mellitus, cardiac rhythm disturbances during sleep, determination of body weight index (BWI), Mallampati score. An employee is referred to a risk group of OSAS, following the rule: presence of one of the following signs: snoring, obesity with BMI ≥ 30, daytime sleepiness or sleepiness at work with total score ≥ 7 by Epworth questionnaire or presence of one of the following signs: arterial hypertension, diabetes mellitus, disturbed heart rhythm during sleep, structure of oropharynx of 3-4 class according to Mallampati in combination with one of signs: snoring, obesity with BMI ≥ 30, daytime sleepiness or sleepiness at work with total score ≥ 7 by Epworth questionnaire.
EFFECT: method enables forming a risk group of obstructive sleep apnoea/hypopnea syndrome (OSAS) at the stage of medical examinations of employees, detecting OSAS, diagnosing and eliminating it in a timely manner.
1 cl, 2 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING METABOLIC SYNDROM | 2010 |
|
RU2452523C1 |
METHOD OF DETERMINING INDICATIONS FOR POLYSOMNOGRAPHIC EXAMINATION OF PATIENTS WITH ARTERIAL HYPERTENSION | 2007 |
|
RU2372025C2 |
METHOD FOR DETERMINING RESPIRATORY, CARDIOVASCULAR AND METABOLIC DISORDERS RISK DEGREE IN PATIENTS SUFFERING FROM DESTRUCTIVE RESPIRATION DISORDERS IN SLEEPING | 2005 |
|
RU2308886C2 |
METHOD FOR DETERMINATION OF INDICATIONS FOR POLYSOMNOGRAPHY IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME | 2009 |
|
RU2412644C1 |
METHOD OF TREATING SLEEP DISTURBANCES IN BOYS WITH OBESITY | 2012 |
|
RU2479841C1 |
METHOD OF VEGETATIVE IMBALANCE CORRECTION FOR MEN WITH OBSTRUCTIVE APNEA-HYPOPNEA SYNDROME COMBINED WITH ARTERIAL HYPERTENSION | 2015 |
|
RU2609051C1 |
METHOD FOR COMPLEX TREATMENT OF METABOLIC SYNDROME | 2015 |
|
RU2616125C1 |
METHOD OF TREATING METABOLIC SYNDROME | 2015 |
|
RU2583944C1 |
METHOD FOR PREDICTION OF ATRIAL FIBRILLATION DEVELOPMENT IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME | 2022 |
|
RU2793677C1 |
METHOD FOR PREDICTING THE ONE-YEAR RISK OF ADVERSE CARDIOVASCULAR EVENTS IN MEN AFTER DECOMPENSATION OF CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION AND OBSTRUCTIVE SLEEP APNEA SYNDROME | 2021 |
|
RU2767266C1 |
Authors
Dates
2024-05-03—Published
2022-12-16—Filed